Case of morphine-induced ventricular fibrillation
- PMID: 29123613
- PMCID: PMC5675976
- DOI: 10.5847/wjem.j.1920-8642.2017.04.013
Case of morphine-induced ventricular fibrillation
Conflict of interest statement
Conflicts of interest: The authors declare that there are no conflicts of interest relevant to the content of the article.
Figures
References
-
- Steg PG, James SK, Atar D, Badano LP, Lundqvist CB, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–619. - PubMed
-
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Eur Heart J. 2016;37(27):2129–200. - PubMed
-
- Murphy DB, Murphy MB. Opioid antagonist modulation of ischaemia-induced ventricular arrhythmias:a peripheral mechanism. J Cardiovasc Pharmacol. 1999;33(1):122–5. - PubMed
-
- Lee G, Low RI, Amsterdam EA, DeMaria AN, Huber PW, Mason DT. Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction. Clin Pharmacol Ther. 1981;29(5):576–81. - PubMed
-
- Alderman EL, Barry WH, Graham AF, Harrison DC. Hemodynamic effects of morphine and pentazocine differ in cardiac patients. N Engl J Med. 1972;287(13):623–7. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources